Replies to post #68792 on Biotech Values

[exwannabe]

RE: GNVC– I found this analysis interesting and persuasive.

Would it not also be the case that the KM curves very likely are crossed well into 12 months are so? And if so, that invalidates a log-rank test?

And the company elected to conceal the curve?

I doubt it matters how the final events play out, unless by some miracle enough early events come in favorable enough to change the picture (I have no idea if enrollment timeline even makes this possible).